People

Don Des Jarlais
Don C. Des Jarlais, PhD
CDUHR - Associate Director, Infectious Disease Epidemiology and Social-behavioral Theory Core
NYU School of Global Public Health - Professor Emeritus
Email: don.desjarlais@nyu.edu
Education
PhD, Social Psychology, University of Michigan, Ann Arbor
BA, Behavioral Science, Rice University
Research Interests
Injecting drug use, Epidemiology, HIV, HCV, Research synthesis
BIO
For over 40 years Don Des Jarlais has been conducting HIV/AIDS research among persons who inject drugs (PWID). He is PI of the “Risk Factors” study (R01DA003574), which was instrumental in tracking the HIV/AIDS epidemic in New York City. This study has been funded by the National Institute on Drug Abuse since 1983 and is the longest continuously funded study on HIV/AIDS in persons who use drugs. He has conducted HIV/AIDS research nationally (Seattle, CDC CIDUS studies, national syringe exchange survey) and internationally (in over 20 different countries). He has served as a consultant on these issues to the World Health Organization, the National Institutes of Health and the U.S. Centers for Disease Control and Prevention.
Projects
Principal Investigator, Risk Factors for AIDS among Persons Who Inject Drugs: HIV and COVID-19. Active
Principal Investigator, Barriers to Reason: Laws Impacting HIV Prevention Efforts among IDUs in the United States. Completed
Principal Investigator, Combined HIV Prevention for PWID and Future Collaborative Research in Vietnam. Completed
Principal Investigator, Combined Prevention to Reduce Initiation Into Injecting Drug Use. Completed
Principal Investigator, DRIVE (Drug Use and Blood-Borne Infections in Vietnam): Combined Prevention and Care to End the HIV Epidemic Among People Who Inject Drugs in Haiphong, Vietnam. Completed
Principal Investigator, Evaluating ART for All HIV Seropositives: Can It Work with the Hardest Cases?. Completed
Principal Investigator, Expanded Syringe Access Program: NY Evaluation (ESAP). Completed
Principal Investigator, HIV Infection in Ethnic Minority IDUs: An International Systematic Review. Completed
Principal Investigator, HIV Transmission among Injecting and Non-Injecting Drug Users in Tallinn, Estonia. Completed
Principal Investigator, Multiple HIV Prevention Packages for IDUs in Estonia. Completed
Principal Investigator, National Study of Syringe Exchange Programs. Completed
Principal Investigator, WHO Survey Coordinating Center, Drug Injecting Study – Phase 2. Completed
Publications

Recent

Kimball S, Weng CA, McKnight C, Khezri M, Des Jarlais DC (2025).
Naloxone carriage among people who inject drugs in New York City
Drug and Alcohol Review, 44 (7), 1847-1855. doi: 10.1111/dar.70018.

Hong TT, Huong DT, Khue PM, Binh NT, Vallo R, D'Ottavi M, Giang HT, Vinh VH, Oanh KT, Tranh NTT, Duc NQ, Quillet C, Rapoud D, Van de Perre P, Feelemyer J, Michel L, Laureillard D, Des Jarlais D, Moles JP, Nagot N (2025).
Hepatitis C virus incidence trend and its risk factors among people who inject drugs in Hai Phong, Vietnam
Hepatology International, 19 (5), 1077-1086. doi: 10.1007/s12072-025-10856-w. PMCID: PMC12508010.

Abel-Ollo K, Tonisson M, Rausberg P, Riikoja A, Barndok T, Oja M, Denissov G, Des Jarlais D, Uuskula A (2025).
The nitazene epidemic in Estonia: A first report
European Journal of Public Health [Epub 2025 Sep 23]. doi: 10.1093/eurpub/ckaf160.

Behrends CN, Des Jarlais DC, Luhur W, Lu X, Corry GJ, Glick SN, Kapadia SN, Perlman DC, Schackman BR (2025).
On-site health service delivery models at syringe services programs in the United States: Results of a national cross-sectional survey
Drug and Alcohol Dependence Reports, 16, 100355. doi: 10.1016/j.dadr.2025.100355. PMCID: PMC12273473.

Trickey A, Walker JG, Khue PM, Hong TT..., Des Jarlais D, ...Vickerman P (2025).
Impact and cost-effectiveness of interventions to eliminate hepatitis C virus among people who inject drugs in Haiphong, Vietnam
International Journal of Drug Policy, 143, 104898. doi: 10.1016/j.drugpo.2025.104898.


Notable

Des Jarlais DC, Huong DT (2018).
Ending HIV epidemics among people who inject drugs in LMICs
Lancet, 392 (10149), 714-719. doi: 10.1016/S0140-6736(18)31721-5.

Dr. Des Jarlais' ResearchGate Profile
Selected Press